31 August 2024
Sidley Advises on the US$220 Million IPO of Akums Drugs and Pharmaceuticals Limited
Advising firms
Deal team
8 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Manoj Bhargava Lead | Sidley | Partner | Not stated | Not stated |
| Harekrishna J. Ashar | Sidley | Not stated | Not stated | Not stated |
| Dhanush Dinesh | Sidley | Not stated | Not stated | Not stated |
| Carla G. Teodoro | Sidley | Not stated | Not stated | Not stated |
| Nicholas R. Brown | Sidley | Not stated | Not stated | Not stated |
| Prabhat K. Mehta | Sidley | Not stated | Not stated | Not stated |
| Robert M. Kreitman | Sidley | Not stated | Not stated | Not stated |
| Alvin Wang | Sidley | Not stated | Not stated | Not stated |
Stated terms
- Stated value
- USD 220m (US$220 million)
- What the figure measures
- Issue size
- Client
- Not stated
- Counterparties
- ICICI Securities (Underwriters)
Axis Capital (Underwriters)
Citigroup Global Markets India (Underwriters)
Ambit (Underwriters)
Akums Drugs and Pharmaceuticals Limited (Issuer)